Stability of HIV-1 nucleic acids in dried blood spot samples for HIV-1 drug resistance genotyping

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Aitken, Susan C ^a   Wallis, Carole L ^b   Stevens, Wendy ^c,d   De Wit, Tobias Rinke ^e,f   Schuurman, Rob ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LANCET LABORATORIES   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e PharmAccess International   (Netherlands)

^f AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA; NUCLEIC ACID;

ARTICLE; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; ENVIRONMENTAL TEMPERATURE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; HUMAN TISSUE; MOLECULAR STABILITY; NONHUMAN; PROVIRUS; STORAGE TEMPERATURE; VIRUS RESISTANCE; ANTIVIRAL RESISTANCE; GENETICS; GENOTYPING TECHNIQUE; METABOLISM; PROCEDURES; SPECIMEN HANDLING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

DRUG RESISTANCE, VIRAL; GENOTYPE; GENOTYPING TECHNIQUES; HIV-1; HUMANS; NUCLEIC ACIDS; RNA, VIRAL; SPECIMEN HANDLING;

EID: 84940056659     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131541     Document Type: Article

References (44)

1. Ayele W, Schuurman R, Messele T, Dorigo-Zetsma W, Mengistu Y, et al. (2007) Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immuno-deficiency virus type 1 burden. J Clin Microbiol 45: 891-896. PMID: 17251400
2. Fiscus SA, Brambilla D, Grosso L, Schock J, Cronin M (1998) Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper. J Clin Microbiol 36: 258-260. PMID: 9431960
3. McNulty A, Jennings C, Bennett D, Fitzgibbon J, Bremer JW, et al. (2007) Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol 45: 517-521. PMID: 17166967
4. Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, et al. (2006) A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance. J Virol Methods 133: 137-145. PMID: 16375980
5. Alvarez-Munoz MT, Zaragoza-Rodriguez S, Rojas-Montes O, Palacios-Saucedo G, Vazquez-Rosales G, et al. (2005) High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions. Arch Med Res 36: 382-386. PMID: 15950079
6. Brambilla D, Jennings C, Aldrovandi G, Bremer J, Comeau AM, et al. (2003) Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol 41: 1888-1893. PMID: 12734222
7. Cassol S, Gill MJ, Pilon R, Cormier M, Voigt RF, et al. (1997) Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper. J Clin Microbiol 35: 2795-2801. PMID: 9350736
8. Leelawiwat W, Young NL, Chaowanachan T, Ou CY, Culnane M, et al. (2009) Dried blood spots for the diagnosis and quantitation of HIV-1: stability studies and evaluation of sensitivity and specificity for the diagnosis of infant HIV-1 infection in Thailand. J Virol Methods 155: 109-117. doi: 10.1016/j.jviromet. 2008.09.022 PMID: 18952125
9. Monleau M, Butel C, Delaporte E, Boillot F, Peeters M (2010) Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping. J Antimicrob Chemother 65: 1562-1566. doi: 10.1093/jac/dkq205 PMID: 20542904
10. Waters L, Kambugu A, Tibenderana H, Meya D, John L, et al. (2007) Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 46: 590-593.
11. Bertagnolio S, Soto-Ramirez L, Pilon R, Rodriguez R, Viveros M, et al. (2007) HIV-1 drug resistance surveillance using dried whole blood spots. Antivir Ther 12: 107-113. PMID: 17503754
12. Youngpairoj AS, Masciotra S, Garrido C, Zahonero N, de Mendoza C, et al. (2008) HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C. J Antimicrob Chemother 61: 1217-1220. doi: 10.1093/jac/dkn100 PMID: 18344550
13. Ziemniak C, George-Agwu A, Moss WJ, Ray SC, Persaud D (2006) A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J Virol Methods 136: 238-247. PMID: 16828172
14. Buckton AJ, Bissett SL, Myers RE, Beddows S, Edwards S, et al. (2008) Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. J Antimicrob Chemother 62: 1191-1198. doi: 10.1093/jac/dkn412 PMID: 18927229
15. Chew CB, Potter SJ, Wang B, Wang YM, Shaw CO, et al. (2005) Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART. J Clin Virol 33: 206-216. PMID: 15911442
16. Hallack R, Doherty LE, Wethers JA, Parker MM (2008) Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay. J Clin Virol 41: 283-287. doi: 10.1016/j.jcv.2007.12.011 PMID: 18243787
17. Hearps AC, Ryan CE, Morris LM, Plate MM, Greengrass V, et al. (2010) Stability of dried blood spots for HIV-1 drug resistance analysis. Curr HIV Res 8: 134-140. PMID: 20163343
18. Masciotra S, Garrido C, Youngpairoj AS, McNulty A, Zahonero N, et al. (2007) High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. Aids 21: 2503-2511. PMID: 18025887
19. Parisi SG, Boldrin C, Cruciani M, Nicolini G, Cerbaro I, et al. (2007) Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients. J Clin Microbiol 45: 1783-1788. PMID: 17442799
20. Steegen K, Luchters S, Demecheleer E, Dauwe K, Mandaliya K, et al. (2007) Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots. J Clin Microbiol 45: 3342-3351. PMID: 17670924
21. Venturi G, Romano L, Carli T, Corsi P, Pippi L, et al. (2002) Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy. Antivir Ther 7: 245-250. PMID: 12553478
22. Coffin JM (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267: 483-489. PMID: 7824947
23. Drake JW, Holland JJ (1999) Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96: 13910-13913. PMID: 10570172
24. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582-1586. PMID: 8599114
25. Kearney M, Palmer S, Maldarelli F, Shao W, Polis MA, et al. (2008) Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase. AIDS 22: 497-501. doi: 10.1097/QAD. 0b013e3282f29478 PMID: 18301062
26. Ribeiro RM, Bonhoeffer S, Nowak MA (1998) The frequency of resistant mutant virus before antiviral therapy. AIDS 12: 461-465. PMID: 9543443
27. Barth RE, Aitken SC, Tempelman H, Geelen SP, van Bussel EM, et al. (2012) Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients. Antivir Ther 17: 377-386. doi: 10.3851/IMP2010 PMID: 22297391
28. Riva E, Pistello M, Narciso P, D'Offizi G, Isola P, et al. (2001) Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. AIDS Res Hum Retroviruses 17: 1599-1604. PMID: 11779347
29. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS (1987) Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800-802. PMID: 3313729
30. Aitken SC, Bronze M, Wallis CL, Stuyver L, Steegen K, et al. (2013) A Pragmatic Approach to HIV-1 Drug Resistance Determination in Resource-Limited Settings using a Novel RT-only Genotyping Assay. J Clin Microbiol 51: 1757-1761. doi: 10.1128/JCM.00118-13 PMID: 23536405
31. Grant RM, Kuritzkes DR, Johnson VA, Mellors JW, Sullivan JL, et al. (2003) Accuracy of the TRUGENE HIV-1 genotyping kit. J Clin Microbiol 41: 1586-1593. PMID: 12682149
32. Korn K, Reil H, Walter H, Schmidt B (2003) Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results. J Clin Microbiol 41: 3559-3565. PMID: 12904355
33. Schuurman R, Brambilla D, de Groot T, Huang D, Land S, et al. (2002) Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program. AIDS Res Hum Retroviruses 18: 243-248. PMID: 11860670
34. Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, et al. (1999) Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol 37: 2291-2296. PMID: 10364600
35. Rottinghaus EK, Beard RS, Bile E, Modukanele M, Maruping M, et al. (2014) Evaluation of dried blood spots collected on filter papers from three manufacturers stored at ambient temperature for application in HIV-1 drug resistance monitoring. PLoS One 9: e109060. doi: 10.1371/journal.pone.0109060 PMID: 25303690
36. Saracino A, Gianotti N, Marangi M, Cibelli DC, Galli A, et al. (2008) Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. J Med Virol 80: 1695-1706. doi: 10.1002/jmv.21261 PMID: 18712823
37. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183-188. PMID: 9144289
38. Sanchez G, Xu X, Chermann JC, Hirsch I (1997) Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J Virol 71: 2233-2240. PMID: 9032358
39. Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, et al. (1995) In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med 1: 1284-1290. PMID: 7489410
40. Harper ME, Marselle LM, Gallo RC, Wong-Staal F (1986) Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A 83: 772-776. PMID: 3003749
41. Drosten C, Panning M, Drexler JF, Hansel F, Pedroso C, et al. (2006) Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5′ long terminal repeat domain. Clin Chem 52: 1258-1266. PMID: 16627558
42. Viljoen J, Gampini S, Danaviah S, Valea D, Pillay S, et al. (2010) Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J Acquir Immune Defic Syndr 55: 290-298. doi: 10.1097/QAI.0b013e3181edaaf5 PMID: 20700058
43. Aitken SC, Kliphuis A, Wallis CL, Chu ML, Fillekes Q, et al. (2012) Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes. J Clin Virol 54: 21-25. doi: 10.1016/j.jcv.2012.01.010 PMID: 22306272
44. Wallis CL, Papathanasopoulos MA, Lakhi S, Karita E, Kamali A, et al. (2010) Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. J Virol Methods 163: 505-508. doi: 10.1016/j.jviromet.2009.11.011 PMID: 19917318